NANOVIRICIDES, INC. Proceeds from Issuance or Sale of Equity
NANOVIRICIDES, INC. (NNVC) reported Proceeds from Issuance or Sale of Equity of $21.96 thousand for the 3-month period ending 2025-12-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2026-05-15
- NANOVIRICIDES, INC. proceeds from issuance or sale of equity for the quarter ending 2025-12-31 was $21.96K, a 78.76% decline year-over-year.
- NANOVIRICIDES, INC. proceeds from issuance or sale of equity for the quarter ending 2025-09-30 was $44.27K, a 20.78% decline year-over-year.
- NANOVIRICIDES, INC. proceeds from issuance or sale of equity for the quarter ending 2025-03-31 was $103.42K.
- NANOVIRICIDES, INC. proceeds from issuance or sale of equity for the quarter ending 2024-12-31 was $103.42K.
- NANOVIRICIDES, INC. proceeds from issuance or sale of equity for fiscal 2025 was $202.75K, a 72.82% increase from fiscal 2024.
- NANOVIRICIDES, INC. proceeds from issuance or sale of equity for fiscal 2024 was $117.31K.
| Period end | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 3 month as first filed | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $21.96K 10-Q · filed 2026-05-15 | $66.24K derived: sum of 2 quarters · filed 2026-05-15 | |||
| 2025-09-30 | $44.27K 10-Q · filed 2026-05-15 | ||||
| 2025-06-30 | $202.75K 10-K · filed 2025-09-29 | ||||
| 2025-03-31 | $103.42K 10-Q · filed 2026-05-15 | $19.03K 10-Q · filed 2025-05-15 | $206.84K derived: sum of 2 quarters · filed 2026-05-15 | $262.73K derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | $103.42K 10-Q · filed 2026-05-15 | $159.31K derived: sum of 2 quarters · filed 2026-05-15 | |||
| 2024-09-30 | $55.89K 10-Q · filed 2026-05-15 | $53.88K 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | $117.31K 10-K · filed 2025-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |